Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy P Patterson

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal of Immunology (Baltimore, Md. : 1950)|February 14, 2012
Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in miceAsada Leelahavanichkul, Alexander V Bocharov, Roger Kurlander, et al.
Canadian Journal of Gastroenterology & Hepatology|October 23, 2018
Colon Epithelial MicroRNA Network in Fatty LiverPaule V Joseph, Sarah K Abey, Dan Wang, et al.
Kidney International|March 21, 2016
Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulationAna Carolina P Souza, Alexander V Bocharov, Irina N Baranova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 5, 2014
T-cell immunotherapy: looking forwardJacqueline Corrigan-Curay, Hans-Peter Kiem, David Baltimore, et al.
NEJM Evidence|October 22, 2024
Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical TrialsSonia M Thomas, Robert A Harrington, Clyde W Yancy, et al.
Human Gene Therapy|April 30, 2014
Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013Marina O'Reilly, Howard J Federoff, Yuman Fong, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of Immunology (Baltimore, Md. : 1950)|February 14, 2012
Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in miceAsada Leelahavanichkul, Alexander V Bocharov, Roger Kurlander, et al.
Canadian Journal of Gastroenterology & Hepatology|October 23, 2018
Colon Epithelial MicroRNA Network in Fatty LiverPaule V Joseph, Sarah K Abey, Dan Wang, et al.
Kidney International|March 21, 2016
Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulationAna Carolina P Souza, Alexander V Bocharov, Irina N Baranova, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 5, 2014
T-cell immunotherapy: looking forwardJacqueline Corrigan-Curay, Hans-Peter Kiem, David Baltimore, et al.
NEJM Evidence|October 22, 2024
Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical TrialsSonia M Thomas, Robert A Harrington, Clyde W Yancy, et al.
Human Gene Therapy|April 30, 2014
Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013Marina O'Reilly, Howard J Federoff, Yuman Fong, et al.
Pageof 5